Navigation Links
Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
Date:11/6/2007

MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced results from a study demonstrating the important role of Haptoglobin (Hp) typing in determining the risk of cardiovascular complications in patients with diabetes. Presented today at the American Heart Association Scientific Sessions 2007, the data show that tight glycemic control in patients with diabetes appears most effective in reducing cardiovascular events in patients who possess the Hp2-2 phenotype.

"This study provides, for the first time, strong prospective evidence that tight glucose monitoring and control can dramatically benefit certain identifiable patients with diabetes," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista. "While it is widely accepted that tight glycemic control can limit microvascular disease like retinopathy in patients with diabetes, the potential benefits of such control on macrovascular disease have been less clear. This large, prospective evaluation of Hp typing, for which Synvista is developing a clinical diagnostic test, demonstrates how 40% of diabetic patients can achieve significant cardiovascular benefit from tight glycemic control. We believe the findings of this study further validate our approach to target the treatment of heart disease in diabetic patients by using Hp testing for patient risk stratification, as we advance our lead product candidates, ALT-2074 and alagebrium, through clinical development."

In a presentation titled "Tight Diabetic Glycemic Control Reduces the Risk of Cardiovascular Disease Only in Individuals With the Hp2-2 Genotype," Shany Blum, M.D., of the Rappaport Institute of the Technion University, Haifa, Isr
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
2. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
3. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... HEIDELBERG, Germany, Dec. 2 febit...ners of the "Top 10 Innovations of 2009" by The S...ce capture technology for high-throughput sequenci...s of invention, vision and utility. ,, The Sc...uate a broad range of life science technologies an...
(Date:12/2/2009)... 2 TeamHealth Teleradiology ( www....largest provider of hospital-based clinical outsou...ovide teleradiology services for two groups in Sou...d with UpState Carolina Radiology located in Spart...to provide services for the following four hospita...
(Date:12/2/2009)... Decision Resources, one of the wor...aceutical and healthcare issues, finds that generi...antipsychotics will cause the schizophrenia drug m...2 billion in 2013 in the United States, France, Ge... ,, The new Pharmacor report entitled Schizoph...
Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Mt Lebanon Comes Alive Saturday August 8th with ULTRAparty 52936 1Mt Lebanon Comes Alive Saturday August 8th with ULTRAparty 52936 2Mylan Reports That the FDA Determined That All Accusations Were Unfounded 52934 1Mylan Reports That the FDA Determined That All Accusations Were Unfounded 52934 2Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 1Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 2Survey Finds 64 25 of Americans Unaware Sunscreen Inhibits Vitamin D Production 52932 3
...otential to Demonstrate an Effect,on a Serious or ...May 07, 2007 /PRNewswire-FirstCall/ -- Cell,Therap...t track,designation from the U.S. Food and Drug Ad...enedione, being investigated for the,potential tre...kin,s lymphoma (NHL). In granting fast track, the ...
....S. Food and Drug,Administration (FDA) today propo...update the existing black box warning on,their pro...d risks,of suicidal thinking and behavior, known a...g initial treatment (generally the first,one to tw...clude language stating that,scientific data did no...
Other Medicine Technology:Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 2Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 3Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 4Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 5FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 2FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 3
(Date:12/2/2009)...e a prostate-specific antigen (PSA) value of less ...eam radiation therapy (EBRT) are less likely to ha...ccording to a study in the December 1 issue of the...gy*Physics, the official journal of the American S...ls in a prostate cancer patient are monitored afte...
(Date:12/2/2009)...ed movement therapy (CIMT) is a potentially effect...gic cerebral palsy, but more research is needed, a...he November issue of Physical Therapy (PTJ), the...py Association (APTA). The review, which analyzed ...concluded that further research should focus on th...
(Date:12/2/2009)... Aid has been a top name in the medical supply ind...roducts, professional staff, and a keen understand...id has established itself as a provider of ground ...rst aid supplies distributor. The distinguished hi...to its next phase with the redesign and launch of ...
(Date:12/2/2009)... Race Series to increase awareness of prostate can...rtance of early detection , ...en, families, friends and neighbors – at all... in the Rudolph Ramble 5K. The Rudolph Ramble 5K ...h was launched by the Prostate Conditions Educati...
(Date:12/2/2009)...f Kendall Hunt authors earned the 2009 Gifted Chil...National Association for Gifted Children’s a... , Dubuque, IA (PRWEB) De...arned the 2009 Gifted Child Quarterly Paper of the... Gifted Children’s annual conference in St. ...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2
... Alternative Reproductive Resources ( ARR ) toda...parents avoid some of the pitfalls of "do-it-yours...rogate Management Services , the Chicago egg dona... not likely to be equipped to handle on their own....
...ns to reduce the spread of HIV and other sexually ...ples and ethnically diverse populations continues ...s issue, NIMH awarded a two-year grant to David Pr...ention designed for young, heterosexual Latino cou...
...ting Offline , , CINCINNATI, May 26 A new study ...enage girls present themselves online. , , The st...ows that teen girls who would depict themselves on...uals offline. , , Moreover, 40 percent of all 173...
...e judicial experience than any Supreme Court nomin..."Judge Sotomayor,s nomination to be a Supreme Cour...cans. As a Latina and a mother, I can say to my da...ispanic health advocacy group. , , Dr. Delgado s...
...m, The Netherlands and San Antonio, TX, USA John ... of the 2009 Alzheimer Award presented by the Jou... outstanding work, "Identification of miRNA change...ell et al. , "My co-authors and I are extremely ...
... , Philadelphia, Pa. (V... attend the second annual Partnerships for the Chi...hildren, as they honor and recognize Daniel J. Hil...dren throughout the Delaware Valley. , , ,Northern...
Other Medicine News:Health News:New Program Offsets Risks of 'Do-It-Yourself' Gestational Surrogacy 2Health News:HIV prevention program gets a boost from NIMH recovery act funds 2Health News:Study Demonstrates Internet Risks for Teen Girls 2Health News:Study Demonstrates Internet Risks for Teen Girls 3Health News:John P. Cogswell, Ph.D., receives 2009 Alzheimer Award 2Health News:AmeriHealth Mercy President and CEO Daniel J. Hilferty to be Honored by Northern Home for Children at its Annual Partnerships for the Children Awards Dinner 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: